AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
CABOTEGRAVIR in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APRETUDE Film Coated Tablets | Rwanda FDA-HMP-MA-2062 | Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) | active | 29 Sept 2029 |
CABOTEGRAVIR — RDA Registration Details
RDA (Rwanda) has 1 registered product containing CABOTEGRAVIR, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track CABOTEGRAVIR registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.